Transition mutation in codon 248 of the p53 tumor suppressor gene induced by reactive oxygen species and a nitric oxide-releasing compound

被引:39
作者
Souici, AC
Mirkovitch, J
Hausel, P
Keefer, LK
Felley-Bosco, E
机构
[1] Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland
[2] Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland
[3] NCI, Frederick Canc Res & Dev Ctr, Comparat Carcinogenesis Lab, Chem Sect, Ft Detrick, MD 21702 USA
关键词
D O I
10.1093/carcin/21.2.281
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Exposing the human bronchial epithelial cell line BEAS2B to the nitric oxide (NO) donor sodium 1-(N,N-diethylamino)diazen-1-ium-1,2-diolate (DEA/NO) at an initial concentration of 0.6 mM while generating superoxide ion at the rate of 1 mu M/min with the hypoxanthine/xanthine oxidase (HX/XO) system induced C:G-->T:A transition mutations in codon 248 of the p53 gene. This pattern of mutagenicity was not seen by 'fish-restriction fragment length polymorphism/polymerase chain reaction' (fish-RFLP/PCR) on exposure to DEA/NO alone, however, exposure to HX/XO led to various mutations, suggesting that co-generation of NO and superoxide was responsible for inducing the observed point mutation. DEA/NO potentiated the ability of HX/XO to induce lipid peroxidation as well as DNA single- and double-strand breaks under these conditions, while 0.6 mM DEA/NO in the absence of HX/XO had no significant effect on these parameters. The results show that a point mutation seen at high frequency in certain common human tumors can be induced by simultaneous exposure to reactive oxygen species and a NO source.
引用
收藏
页码:281 / 287
页数:7
相关论文
共 50 条
  • [21] Dominant-negative mutation of p53 tumor suppressor gene in endometrial carcinoma
    Sakuragi, N
    Hirai, A
    Tada, M
    Yamada, H
    Yamamoto, R
    Fujimoto, S
    Moriuchi, T
    GYNECOLOGIC ONCOLOGY, 2001, 83 (03) : 485 - 490
  • [22] OXY-RADICAL INDUCED MUTAGENESIS OF HOTSPOT CODON-248 AND CODON-249 OF THE HUMAN P53 GENE
    HUSSAIN, SP
    AGUILAR, F
    AMSTAD, P
    CERUTTI, P
    ONCOGENE, 1994, 9 (08) : 2277 - 2281
  • [23] Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species
    Karawajew, L
    Rhein, P
    Czerwony, G
    Ludwig, WD
    BLOOD, 2005, 105 (12) : 4767 - 4775
  • [24] Polymorphism of tumor suppressor gene (p53) Codon 72 in Iraqi patients with acute myocardial infarction
    Al-Tu'ma, Fadhil Jawad
    Al-Zubaidi, Riyadh D.
    Al-Khaleeli, Abdul-Mutalib Badr
    Abo-Almaali, Hassan M.
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2016, 2 (07): : 74 - 76
  • [25] Nitric oxide-evoked accumulation of the tumor suppressor p53:: Mechanism of NO-action
    Schneiderhan, N
    Budde, A
    Brüne, B
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R47 - R47
  • [26] Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis
    Ye, JP
    Wang, SW
    Leonard, SS
    Sun, Y
    Butterworth, L
    Antonini, J
    Ding, M
    Rojanasakul, Y
    Vallyathan, V
    Castranova, V
    Shi, XL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) : 34974 - 34980
  • [27] Detection of p53 tumor suppressor gene mutation in advanced gastric carcinoma is not independently prognostic
    Fuke, T
    Iinuma, H
    Fukushima, R
    Okinaga, K
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 343 - 346
  • [28] ABNORMALLY EXPRESSED TUMOR-SUPPRESSOR GENE P53 IN PTERYGIUM IS DUE TO POINT MUTATION
    TAN, DTH
    CAI, B
    SMITH, DR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S35 - S35
  • [29] The mouse lymphoma L5178Y Tk(+/-) cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene
    Storer, RD
    Kraynak, AR
    McKelvey, TW
    Elia, MC
    Goodrow, TL
    DeLuca, JG
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1997, 373 (02) : 157 - 165
  • [30] Point mutation of tumor suppressor gene p53 in two highly malignant metastatic insulinomas
    Pavelic, K
    Hrascan, R
    Cabrijan, T
    Krizanac, S
    Eljuga, D
    Pavelic, J
    Karapandza, N
    Kusic, Z
    Spaventi, S
    TUMORDIAGNOSTIK & THERAPIE, 1997, 18 (04) : 102 - 106